Skip to main content Skip to footer

Company
Science
Investors
News & Media

Search site

Search

Genflow Reports Sustained Safety and Efficacy Three Months Post Dosing in SLAB Trial

April 8, 2026

Newsletter

To stay up to date with news, events and more, sign up to our mailing list and follow our social media

Subscription Form

Contact

For more information on Genflow Bioscience and our science, get in touch.

Company

About
Leadership
Careers

Science

Overview
Product Pipeline
Clinical Programs

News

RNS
Insights
Publications

Follow Genflow Bioscience on LinkedIn
Follow Genflow Bioscience on X (twitter)
Follow Genflow Bioscience on Instagram

Copyright 2026 © Genflow Bioscience

Privacy Policy
Disclaimer
Terms of Use

Home
About
- Leadership
Genflow Biosciences
- Product Pipeline
- Clinical Programs
Investors
Contact
Publications